Literature DB >> 11817188

Neonatal complications of preterm premature rupture of membranes. Pathophysiology and management.

H W Kilbride1, D W Thibeault.   

Abstract

Midtrimester PROM is an infrequent, yet potentially disastrous complication of pregnancy. The most likely neonatal complication is preterm delivery with associated morbidity and mortality risks. Unique neonatal complications following PPROM include skeletal deformations and pulmonary hypoplasia related to prolonged oligohydramnios exposure. A systematic approach to an infant with respiratory insufficiency following PPROM delivery is possible with an understanding of the pathophysiology of pulmonary hypoplasia. Neonatal management should include immediate resuscitation including surfactant replacement, with careful attention to techniques of mechanical ventilation to avoid early volutrauma. Adjunctive therapies directed at pulmonary hypertension may now permit survival of some infants with less severe forms of pulmonary hypoplasia.

Entities:  

Mesh:

Year:  2001        PMID: 11817188     DOI: 10.1016/s0095-5108(03)00076-9

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  11 in total

1.  Inhaled nitric oxide in preterm infants with prolonged preterm rupture of the membranes: a case series.

Authors:  J Semberova; S M O'Donnell; J Franta; J Miletin
Journal:  J Perinatol       Date:  2015-04       Impact factor: 2.521

2.  Association of Early Inhaled Nitric Oxide With the Survival of Preterm Neonates With Pulmonary Hypoplasia.

Authors:  Kevin R Ellsworth; Marc A Ellsworth; Amy L Weaver; Kristin C Mara; Reese H Clark; William A Carey
Journal:  JAMA Pediatr       Date:  2018-07-02       Impact factor: 16.193

3.  Treatment of premature infants with pulmonary hypertension and right ventricular dysfunction with milrinone: a case series.

Authors:  A T James; C Bee; J D Corcoran; P J McNamara; O Franklin; A F El-Khuffash
Journal:  J Perinatol       Date:  2014-11-27       Impact factor: 2.521

4.  Mortality risk associated with perinatal drug and alcohol use in California.

Authors:  Ellen L Wolfe; Thomas Davis; Joseph Guydish; Kevin L Delucchi
Journal:  J Perinatol       Date:  2005-02       Impact factor: 2.521

5.  Risk factors for pulmonary candidiasis in preterm infants with a birth weight of less than 1250 g.

Authors:  Simonetta Frezza; Luca Maggio; Maria Pia De Carolis; Francesca Gallini; Maria Puopolo; Valentina Polimeni; Simonetta Costa; Giovanni Vento; Giuseppe Tortorolo
Journal:  Eur J Pediatr       Date:  2004-11-13       Impact factor: 3.183

Review 6.  Management of hypoxemic respiratory failure and pulmonary hypertension in preterm infants.

Authors:  N Ambalavanan; J L Aschner
Journal:  J Perinatol       Date:  2016-06       Impact factor: 2.521

Review 7.  Diagnostic Approach to Pulmonary Hypertension in Premature Neonates.

Authors:  Vasantha H S Kumar
Journal:  Children (Basel)       Date:  2017-08-24

8.  Neonatal Outcomes according to the Latent Period from Membrane Rupture to Delivery among Extremely Preterm Infants Exposed to Preterm Premature Rupture of Membrane: a Nationwide Cohort Study.

Authors:  Jae Hyun Park; Jin Gon Bae; Yun Sil Chang
Journal:  J Korean Med Sci       Date:  2021-04-12       Impact factor: 2.153

9.  Midtrimester preterm prelabour rupture of membranes (PPROM): expectant management or amnioinfusion for improving perinatal outcomes (PPROMEXIL - III trial).

Authors:  Augustinus S P van Teeffelen; David P van der Ham; Christine Willekes; Salwan Al Nasiry; Jan G Nijhuis; Sander van Kuijk; Ewoud Schuyt; Twan L M Mulder; Maureen T M Franssen; Dick Oepkes; Fenna A R Jansen; Mallory D Woiski; Mireille N Bekker; Caroline J Bax; Martina M Porath; Monique W M de Laat; Ben W Mol; Eva Pajkrt
Journal:  BMC Pregnancy Childbirth       Date:  2014-04-04       Impact factor: 3.007

10.  Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation predict neonatal pulmonary hypertension? (HOTPOT study protocol).

Authors:  Ann McHugh; Orla Franklin; Afif El-Khuffash; Fionnuala Breathnach
Journal:  Contemp Clin Trials Commun       Date:  2020-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.